Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioWhittaker was a U.S.-based life science company and brand focused on cell culture media, primary cells, endotoxin detection products, and related research and quality-control reagents used by biotechnology and pharmaceutical customers. The business was originally based in Walkersville, Maryland and became known as a supplier of cell culture and diagnostic testing products rather than a therapeutic drug developer. BioWhittaker was acquired by Cambrex in 1997, and Cambrex later sold its bioproducts and biopharma businesses to Lonza in 2007. Today, BioWhittaker persists primarily as a legacy product and trademark brand within Lonza Bioscience, especially for certain cell culture media and reagent lines. It is therefore healthcare-related, but not an active standalone biotech or pharma operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioWhitaker.